BCOR immunohistochemistry: a guide to the stain

A laboratory applies an antibody stain to a thin section from a biopsy or surgical specimen. A pathologist then examines which cells stain and whether the signal is located in their nuclei.

BCOR staining may help narrow a diagnosis when a tumour has a particular microscopic appearance, but the meaning differs among tumour groups. The report may describe staining as retained, lost, focal, or diffuse; those terms describe the observed pattern rather than a diagnosis on their own.

Protein staining cannot identify every possible change in the BCOR gene. If a specific genetic alteration matters for classification, the pathologist may recommend a molecular test and interpret it alongside the stain and other markers.

Start with the final diagnosis, then locate the comment explaining why BCOR was included. Note whether the language is definitive or whether it lists possible diagnoses, pending stains, or genetic confirmation.

Discuss the integrated conclusion with the clinician managing the mass or lesion. When findings are unusual or discordant, specialist pathology review or additional sampling may be considered before a treatment decision is made.

BCOR staining is performed in the laboratory and does not cause symptoms. After a recent biopsy, report spreading redness, increasing warmth, pus-like drainage, worsening swelling, or pain that is becoming stronger rather than settling.

Heavy bleeding, severe shortness of breath, collapse, or sudden confusion needs urgent assessment. Follow the biopsy team's instructions for the specific body area sampled, because expected recovery and warning signs can differ by procedure.

Find out what the BCOR pattern was, which diagnosis it supports, which alternatives remain, and whether a gene-based test is required. Ask if the result changes management now or whether the team must wait for an integrated pathology conclusion.